Mankind Pharma Ltd.’s (MANKIND) 20-Day exponential moving average is 2453.32, while Mankind Pharma Ltd.’s (MANKIND) share price is ₹2,326.8, making it a Sell.

Mankind Pharma Ltd.’s (MANKIND) 50-Day exponential moving average is 2548.22, while Mankind Pharma Ltd.’s (MANKIND) share price is ₹2,326.8, making it a Sell.

Mankind Pharma Ltd. (MANKIND) Pivot Points

Feb 22, 2025, 02:30 PM

Classic

2,280.33

2,302.92

2,324.83

2,347.42

2,369.33

2,391.92

2,413.83

Fibonacci

2,302.92

2,319.92

2,330.42

2,347.42

2,364.42

2,374.92

2,391.92

Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Mankind Pharma Ltd. (MANKIND) Moving Averages

Feb 22, 2025, 02:30 PM

MA5

2,353.97Sell

2,360.10Sell

MA10

2,404.46Sell

2,395.52Sell

MA20

2,449.08Sell

2,453.32Sell

MA50

2,636.14Sell

2,548.22Sell

MA100

2,625.71Sell

2,555.67Sell

MA200

2,428.28Sell

2,437.56Sell

Mankind Pharma Ltd.’s (MANKIND) 10-Day exponential moving average is 2395.52, while Mankind Pharma Ltd.’s (MANKIND) share price is ₹2,326.8, making it a Sell.

Mankind Pharma Ltd.’s (MANKIND) 100-Day exponential moving average is 2555.67, while Mankind Pharma Ltd.’s (MANKIND) share price is ₹2,326.8, making it a Sell.

Mankind Pharma Ltd.’s (MANKIND) stock price is ₹2,326.8 and Mankind Pharma Ltd.’s (MANKIND) 50-day simple moving average is 2636.14, creating a Sell signal.

Mankind Pharma Ltd.’s (MANKIND) stock price is ₹2,326.8 and Mankind Pharma Ltd.’s (MANKIND) 100-day simple moving average is 2625.71, creating a Sell signal.

Mankind Pharma Ltd.’s (MANKIND) stock price is ₹2,326.8 and Mankind Pharma Ltd.’s (MANKIND) 200-day simple moving average is 2428.28, creating a Sell signal.

Mankind Pharma Ltd. (MANKIND) Technical Indicators

Feb 22, 2025, 02:30 PM

RSI (14)

37.40

Neutral

STOCH (9,6)

12.46

Buy

STOCHRSI (14)

10.56

Buy

MACD (12,26)

-74.15

Buy

ADX (14)

14.16

Buy

Williams %R

-95.12

Buy

CCI (14)

-147.72

Buy

ATR (14)

92.24

Ultimate Oscillator

41.23

Neutral

ROC

-9.94

Sell

Mankind Pharma Ltd.’s (MANKIND) Relative Strength Index (RSI) is 37.40, creating a Neutral signal.

Mankind Pharma Ltd.’s (MANKIND) Trend Strength Indicator (ADX) is 14.16, creating a Buy signal.

Mankind Pharma Ltd.’s (MANKIND) Commodity Channel Index (CCI) is -147.72, creating a Buy signal.

Mankind Pharma Ltd.’s (MANKIND) Price Rate of Change (ROC) is -9.94, creating a Sell signal.

Technical Analysis Screener >

Technical Analysis Screener.

Customize your technical analysis to fit your
unique trading strategy with a flexible screener

Try it Now!

FAQ

Is MANKIND a Buy, Hold, or Sell?

Based on MANKIND’s technical indicators, MANKIND is a Sell.

What is MANKIND’s RSI (14)?

MANKIND’s RSI (14) is 37.40, which suggests MANKIND is a Neutral.

What is MANKIND’s MACD?

MANKIND’s MACD is -74.15, which suggests MANKIND is a Buy.

What is MANKIND’s 5-day moving average?

MANKIND’s 5-day moving average is 2353.97, which suggests MANKIND is a Sell.

What is MANKIND’s 20-day moving average?

MANKIND 20-day moving average is 2449.08, which suggests MANKIND is a Sell.

What is MANKIND’s 50-day moving average?

MANKIND’s 50-day moving average is 2636.14, which suggests MANKIND is a Sell.

What is MANKIND’s 200-day moving average?

MANKIND’s 200-day moving average is 2428.28, which suggests MANKIND is a Sell.

What is MANKIND’s Williams % R (14)?

MANKIND’s Williams % R (14) is -95.12, which suggests MANKIND is a Buy.

What is MANKIND’s CCI (14)?

MANKIND’s CCI (14) is -147.72, which suggests MANKIND is a Buy.

What is the share price of Mankind Pharma Ltd.?

Mankind Pharma Ltd.'s share price is N/A₹.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing